|
|
News Breaks | | | | January 17, 2013 | | 11:58 EDT |  | GNK, IPXL, BKD, HAS | High option volume stocks: GNK, RKT, IPXL, BKD, HAS
| |
|
News For GNK;IPXL;BKD;HAS From The Last 14 Days Check below for free stories on GNK;IPXL;BKD;HAS the last two weeks. |
|
|
| May 17, 2013 | | 11:39 EDT | | GNK | High option volume stocks: GNK VNDA BYI ARUN BYI ILMN
 Subscribe for More Information | | | 08:41 EDT |  | IPXL | Impax commenced shipment of authorized generic Zomig
Impax (IPXL) announced that its generics division, Global Pharmaceuticals, commenced shipment of authorized generic Zomig tablets, as part of an agreement with AstraZeneca (AZN). Zomig is indicated for the treatment of migraine headaches in adults. According to IMS Health data, U.S. sales of Zomig tablets and orally disintegrating tablets were approximately $196M in the 12 months ended April 2013. | | | May 15, 2013 | | 11:14 EDT |  | BKD | Brookdale Senior Living community purchases a net positive, says Deutsche Bank
Subscribe for More Information | | | 08:04 EDT | | BKD | Brookdale Senior Living acquires senior living communities for $80.9M
Subscribe for More Information | | | May 13, 2013 | | 07:49 EDT | | IPXL | FDA decision on Opana a modest positive for Impax, says Leerink
Leerink views the FDA's denial of Endo's (ENDP) Citizen Petition as a modest positive for Impax (IPXL), which it notes is the sole holder of 180 day exclusivity on generic Opana. However, Leerink says upside for Impax will be limited as Actavis (ACT), Sandoz, and Teva (TEVA) have settlements to enter the market starting in June 2013 when Impax's 180-day generic exclusivity expires. | | | 06:41 EDT |  | BKD | Brookdale Senior Living management to meet with JMP Securities
Subscribe for More Information | | | May 7, 2013 | | 12:29 EDT | | GNK | High option volume stocks: GNK CVR ACM BA HOLX
Subscribe for More Information | |
|
|
|
|
|
|
